Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Diagnosis, Treatment, and Six-Month Outcome Status in First-Admission Psychosis

Diagnosis, Treatment, and Six-Month Outcome Status in First-Admission Psychosis Six-month outcome status was examined in 202 first-admission inpatients with DSM-III-R schizophrenia spectrum (N = 96), psychotic bipolar disorder (N = 64), and psychotic depression (N = 42) drawn from 10 facilities in Suffolk County, New York. Schizophrenics fared significantly worse on all outcome variables except rehospitalization, which ranged from 17.7 to 23.4%. Bipolars had good psychosocial outcomes regardless of clinical outcome, while the two outcome domains were uncorrelated among schizophrenics and psychotic depressed. Schizophreniform patients had significantly better outcome than those with schizophrenia or schizoaffective disorder. Posthospital treatment was generally unrelated to outcome except that fewer rehospitalized schizophrenics received continuous treatment, and patients with psychotic depression with poorer psychosocial outcome received medication less frequently. These findings highlight the different treatment needs of these diagnostic groups, especially as regards the provision of more intensive rehabilitation for schizophrenic patients and the “poor-outcome” psychotic depressed. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

Diagnosis, Treatment, and Six-Month Outcome Status in First-Admission Psychosis

Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/diagnosis-treatment-and-six-month-outcome-status-in-first-admission-ypBaApcMD8
Publisher
Springer Journals
Copyright
Copyright © 1997 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/A:1026205319204
Publisher site
See Article on Publisher Site

Abstract

Six-month outcome status was examined in 202 first-admission inpatients with DSM-III-R schizophrenia spectrum (N = 96), psychotic bipolar disorder (N = 64), and psychotic depression (N = 42) drawn from 10 facilities in Suffolk County, New York. Schizophrenics fared significantly worse on all outcome variables except rehospitalization, which ranged from 17.7 to 23.4%. Bipolars had good psychosocial outcomes regardless of clinical outcome, while the two outcome domains were uncorrelated among schizophrenics and psychotic depressed. Schizophreniform patients had significantly better outcome than those with schizophrenia or schizoaffective disorder. Posthospital treatment was generally unrelated to outcome except that fewer rehospitalized schizophrenics received continuous treatment, and patients with psychotic depression with poorer psychosocial outcome received medication less frequently. These findings highlight the different treatment needs of these diagnostic groups, especially as regards the provision of more intensive rehabilitation for schizophrenic patients and the “poor-outcome” psychotic depressed.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Sep 18, 2004

References

  • One hundred years of schizophrenia: A meta-analysis of the outcome literature
    Hegarty, JD; Baldessarini, RJ; Tohen, M
  • The discharged psychiatric patient: A review of social, social-psychological, and psychiatric correlates of outcome
    Avison, WR; Speechley, KN
  • The role of social relationships in the course of first-episode schizophrenia and affective psychosis
    Erickson, DH; Beiser, M; Iacono, WG
  • The McLean first-episode psychosis project: Six-month recovery and recurrence outcome
    Tohen, M; Stoll, AL; Strakowski, SM
  • The natural course of schizophrenia: A review of first-admission studies
    Ram, R; Bromet, EJ; Eaton, WW
  • First-episode studies in schizophrenia: Criteria and characterization
    Keshavan, MS; Schooler, NR
  • New directions in diagnosis: The longitudinal processes of schizophrenia
    Strauss, JS; Barto, JJ; Carpenter, WT
  • Concordance of multiple assessments of the outcome of schizophrenia
    Schwartz, CC; Myers, JK; Astrachan, BM
  • Four-year follow-up of twenty-four first-episode manic patients
    Tohen, M; Waternaux, CM; Tsuang, MT
  • Course and outcome in affective disorders
    Bland, RC; Orn, H.
  • Schizophrenia—a follow-up study of results of treatment. II. Hospital stay of over two to five years
    May, PRA; Tuma, AH; Yale, C
  • Neuroleptics and the natural course of schizophrenia
    Wyatt, RJ
  • Fluphenazine vs. placebo in patients with remitted, acute first-episode schizophrenia
    Kane, JM; Rifkin, A; Quitken, F
  • The Northwick Park study of first episodes of schizophrenia. II. A randomized controlled trial of prophylactic neuroleptic treatment
    Crow, TJ; MacMillan, JF; Johnson, AL; Johnstone, E
  • Defining managed care in public-sector psychiatry
    Hoge, MA; Davidson, L; Griffith, EEH
  • Characteristics of private-sector managed care for mental health and substance abuse treatment
    Garnick, DW; Hendricks, AM; Dulski, JD
  • The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description
    Spitzer, RL; Williams, J; Gibbon, M
  • Six-month stability of psychiatric diagnosis in first admission patients with psychosis
    Fennig, S; Kovasznay, B; Rich, C
  • The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome
    Heinrichs, DW; Hanlon, TE; Carpenter, WT
  • The Quick Test: Provisional manual
    Ammons, RB; Ammons, CH
  • Reliability of depression and associated clinical symptoms
    Cicchetti, DV; Prusoff, BA
  • Outcome study of first-episode psychosis. I. Relapse rates after 1 year
    Rabiner, CJ; Wegner, JT; Kane, JM
  • Best-estimate vs. structured interview based diagnosis in first-admission psychosis
    Fennig, S; Craig, TJ; Lavelle, J
  • Time course and biologic correlates of treatment response in first-episode schizophrenia
    Lieberman, J; Jody, D; Geisler, S
  • Affective syndromes, psychotic features, and prognosis. I. Depression
    Coryell, W; Keller, M; Lavori, P
  • Psychotic disorders in DSM-III-R
    Kendler, KS; Spitzer, RL; Williams, JBW
  • European versus US data on the course of schizophrenia
    Marengo, J; Harrow, M; Sands, J
  • Chronicity in schizophrenia: Fact, partial fact, or artifact?
    Harding, CM; Zubin, J; Strauss, JS.
  • National Institute of Mental Health longitudinal study of chronic schizophrenia
    Breier, A; Schreiber, JL; Dyer, J
  • Is modern-day schizophrenic outcome still negative?
    Harrow, M; Grinker, RR; Silverstein, ML
  • Cost of relapse in schizophrenia
    Weiden, PJ; Olfson, M
  • Diagnosis of schizophrenia
    Endicott, J; Nee, J; Cohen, J
  • Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
    Meltzer, HY; Burnett, S; Bastani, B
  • Course of treatment response in first episode and chronic schizophrenia
    Szymanski, SR; Cannon, TD; Gallacher, F